<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30131915</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>24</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Print">2168-8184</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>10</Volume>                    <Issue>6</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Jun</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>Cureus</Title>                <ISOAbbreviation>Cureus</ISOAbbreviation>            </Journal>            <ArticleTitle>Not Your Usual Suspect: Clear Cell Renal Cell Carcinoma Presenting as Ulcerative Esophagitis.</ArticleTitle>            <Pagination>                <MedlinePgn>e2821</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.2821</ELocationID>            <Abstract>                <AbstractText>Renal cell carcinoma (RCC) has the propensity to hematogenously metastasize to the lung, bone, or liver, however, metastasis to the esophagus is exceedingly rare. We report a case of ulcerative esophagitis secondary to recurrent metastatic renal cell cancer status post remote nephrectomy. An 82-year-old Caucasian male presented with dark tarry stools for two days, progressive dysphagia to solid food for several weeks and unintentional weight loss. His past medical history was significant for hypertension, diverticulosis and right-sided renal cell cancer for which he underwent nephrectomy 13 years ago. Physical examination was unremarkable. Laboratory data showed hemoglobin of 12.5 g/dL, with normal platelet count and an international normalized ratio (INR). His stools were positive for occult blood. Esophagogastroduodenoscopy (EGD) revealed a fragile mid esophageal mass and antral erosive gastritis which were both biopsied. Colonoscopy showed diverticulosis without stigmata of active gastrointestinal (GI) bleed. CT scan (computed tomography) of the chest showed a solid esophageal mass in the lower esophagus as well as a right upper lobe lung mass for which CT-guided needle biopsy was obtained. The histopathology revealed metastatic renal cell cancer of clear cell subtype. The patient was started on palliative radiotherapy. On completion of radiotherapy two months later, his dysphagia had resolved. The patient is currently on chemotherapy with Sunitinib. Metastatic involvement of esophagus is relatively uncommon and is reported in 6% of patients with metastatic lung, breast and prostate cancer. Esophageal metastasis of clear cell RCC is very rare and so far only seven cases have been reported. Diagnosis is confirmed by endoscopy, imaging and histopathology. Treatment options include surgical or endoscopic resection for a solitary metastatic lesion. If the tumor is unresectable, multidisciplinary treatment including radiation and chemotherapy is indicated.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ali</LastName>                    <ForeName>Saeed</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Internal Medicine Residency, Florida Hospital, Orlando, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Atiquzzaman</LastName>                    <ForeName>Basher</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Gastroenterology, Florida Hospital Celebration Health, Celebration, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Krall</LastName>                    <ForeName>Konrad</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Interventional Endoscopy, Florida Hospital, Orlando, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kumar</LastName>                    <ForeName>Ranjeet</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Internal Medicine Residency, Florida Hospital, Orlando, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Bo</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Diagnostic Radiology, Florida Hospital, Orlando, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hebert-Magee</LastName>                    <ForeName>Shantel</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Pathology, Florida Hospital, Orlando , USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>06</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cureus</MedlineTA>            <NlmUniqueID>101596737</NlmUniqueID>            <ISSNLinking>2168-8184</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Jpn J Clin Oncol. 1997 Dec;27(6):410-4</RefSource>                <PMID Version="1">9438004</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Drugs. 2015 Jan;26(1):112-6</RefSource>                <PMID Version="1">25075797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Esophagus. 2015;12:91-94</RefSource>                <PMID Version="1">25620904</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Surg. 2009 Jun;96(6):579-92</RefSource>                <PMID Version="1">19434703</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 1975 Dec;114(6):836-8</RefSource>                <PMID Version="1">1195458</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Urol Nephrol. 1995;27(1):1-8</RefSource>                <PMID Version="1">7615361</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1998 Jun;16(6):2261-6</RefSource>                <PMID Version="1">9626229</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 1986 Oct;136(4):805-7</RefSource>                <PMID Version="1">3761436</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nihon Hinyokika Gakkai Zasshi. 1987 Aug;78(8):1394-402</RefSource>                <PMID Version="1">3325678</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">metastasis</Keyword>            <Keyword MajorTopicYN="N">renal cell carcinoma</Keyword>            <Keyword MajorTopicYN="N">sunitinib</Keyword>        </KeywordList>        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30131915</ArticleId>            <ArticleId IdType="doi">10.7759/cureus.2821</ArticleId>            <ArticleId IdType="pmc">PMC6101459</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>